Background and Objective: Semantic memory measures may be useful in tracking and predicting progression of Alzheimer disease. We investigated relationships among semantic memory tasks and their 1-year predictive value in women with Alzheimer disease.
C ognitive processing depends on activity among interconnected nerve cell populations, mediated by synaptic connections. Synapses are lost early in the course of Alzheimer disease (DeKosky and Scheff, 1990; Overk and Masliah, 2014) , the most common cause of dementia (Alzheimer's Association, 2016) . This loss, more than the pathologic burden of characteristic neuritic plaques and neurofibrillary tangles, is the principal morphologic substrate of cognitive decline in this disorder (DeKosky and Scheff, 1990; Overk and Masliah, 2014) .
Impaired episodic memory, a common initial symptom of Alzheimer disease, reflects early pathologic changes in the hippocampus and adjacent entorhinal cortex. Episodic memory-as assessed, for example, by list learning or story recall-reaches a nadir relatively early in the disease course (Locascio et al, 1995; Welsh et al, 1992) . Other cognitive domains are increasingly affected as the cerebral association cortex becomes progressively involved (Braak and Braak, 1991) . Semantic memory requires large networks of neurons in the modality-specific association cortex and heteromodal association cortex (Peelle et al, 2014) , and measures of semantic memory offer a potentially sensitive window on progression in patients with manifest disease.
Semantic deficits can be assessed in several ways. Common tasks involve confrontation naming (eg, naming a visual stimulus, such as an object or the picture of an object) and category fluency (generating word names constrained by semantic relatedness). Other approaches include tests of semantic memory retrieval (eg, retrieval of an object name on the basis of described attributes) and semantic density in structured discourse (number of content words elicited from oral or written narratives).
Here we report secondary analyses of patients with mild-to-moderate dementia from Alzheimer disease, whose assessments at baseline and 1 year later included neuropsychological measures of confrontation naming, category fluency, semantic memory retrieval, and semantic density in written discourse (Henderson et al, 2015) . In this study we examined the extent to which these purported measures of semantic memory related to each other and other cognitive measures; the extent to which these measures reflected dementia staging indicated by assessments of global cognition, dementia severity, and daily function; and the extent to which baseline task performance predicted disease progression. We hypothesized that the semantic memory measures would be associated with dementia staging both in baseline cross-sectional analyses and at 1 year in longitudinal analyses.
METHODS

Participants
The participants were 42 community-dwelling women aged 68 to 89 years with probable Alzheimer disease (McKhann et al, 1984) of mild or moderate severity. They had enrolled in a three-site randomized clinical trial of oral raloxifene hydrochloride versus placebo in women with Alzheimer disease (Henderson et al, 2015) . Raloxifene is a selective estrogen receptor modulator approved to treat osteoporosis in postmenopausal women.
The trial protocol is registered at ClinicalTrials.gov (NCT00368459), and the study was approved by the Stanford University Institutional Review Board. Participants provided written informed consent, or assent with the written consent of their next of kin or a legally authorized representative.
We gave the treatment and placebo groups cognitive and noncognitive tests at baseline and 1 year. The primary clinical trial endpoint was change in the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog).
Results at 1 year failed to suggest cognitive, global, or functional benefit for the women in the raloxifene group (Henderson et al, 2015) .
Cognitive Tasks
We assessed semantic memory with five verbal measures:
Oral confrontation naming: 30-item version of the Boston Naming Test (Mack et al, 1992) . We scored the number of line drawings correctly named without phonemic cues. Oral category fluency: animal naming. We scored the number of unique animal names generated in 60 seconds (Troyer, 2000) . Oral semantic memory retrieval (two measures): Semantic Object Retrieval Test (Kraut et al, 2006 (Kraut et al, , 2007 . Participants first judge semantic associations by deciding whether the combination of two object features leads to the retrieval of a specific object memory and, for any yes response, they then name the object. We scored separately for semantic recognition (the number of correct yes [eg, desert and humps] and no [eg, propeller and ink] responses) and for semantic naming (for correct yes responses, the correct name of the object suggested by the two features [eg, "camel" for desert and humps]). Semantic density in a written narrative: the cookie theft picture from the Boston Diagnostic Aphasia Examination (Goodglass et al, 2001) . We showed the participants a line drawing that depicts children stealing cookies. We gave the participants a blank sheet of paper and instructed, "In the space provided, write as much as you can about what you see going on in this picture" (Appendix A). We scored the number of key people, objects, and actions (Henderson et al, 1992 ) that the participants wrote in their descriptions.
We evaluated other cognitive domains with these tests:
East Boston Memory Test: immediate and delayed recall of a paragraph story (Scherr et al, 1988) List learning: immediate and delayed recall of the ADAS-cog word list (Rosen et al, 1984) A digit ordering task (MacDonald et al, 2001 ) Trail Making Test, Parts A and B (Reitan, 1958) Maze completion and number cancellation developed as supplemental tasks for the ADAS-cog (Mohs et al, 1997) A visuoconstructive (drawing) task embedded within the ADAS-cog (Rosen et al, 1984) The narrative writing score from the cookie theft picture, based on writing mechanics, vocabulary access, syntax, and adequacy of content (Goodglass et al, 2001) Mini-Mental State Examination (Folstein et al, 1975) We determined global cognition psychometrically with this test:
ADAS-cog total score (Rosen et al, 1984) . The ADAScog is a common cognitive endpoint in clinical trials of patients with Alzheimer disease
Noncognitive Endpoints
In addition to global cognition assessed with the ADAS-cog, our other endpoints were dementia severity and daily function. A certified examiner used information from each participant and a knowledgeable informant to rate her dementia severity with the Clinical Dementia Rating sum of boxes score (Morris, 1993) . We assessed her daily function during the preceding 4 weeks with the informant-based Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory of basic and instrumental activities (Galasko et al, 1997) .
Statistical Analyses
We examined Pearson correlations among cognitive variables and trial endpoints. For semantic memory measures, we calculated standardized 1-year change scores using baseline standard deviations. Because semantic recognition and semantic naming scores correlated highly (see below), we also calculated a semantic retrieval composite score as a simpler single measure. The composite score took into account a chance score of 16 on the recognition task. We calculated the semantic retrieval composite score as semantic recognition minus 16 (minimum value set at 0) plus semantic naming (range of possible scores = 0 to 32).
We performed a factor analysis on baseline scores of the cognitive tests to reduce these correlated variables to a smaller set of factors that might represent distinct cognitive abilities. We standardized the 17 baseline test scores to a mean of 0 and a standard deviation of 1 before performing the factor analysis. The only missing baseline scores were baseline maze scores from five participants. We imputed those missing scores using single imputation by fitting a linear regression model to the sample, with baseline maze score as the outcome and baseline composite cognitive score as the main predictor. We then calculated a baseline composite cognitive score using all 17 baseline scores, as described previously (Henderson et al, 2012) . We used an orthogonal varimax rotation procedure to make factors more interpretable.
We modeled associations between cognitive factors and outcome measures separately using multivariable linear regression analysis. We adjusted the analyses for participant age, education, raloxifene versus placebo group, and baseline value of the outcome variable. Similar analyses considered the relation between baseline scores on semantic memory tasks and 1-year outcomes, again adjusting for age, education, raloxifene versus placebo group, and baseline value of the outcome variable.
For the analyses we used Statistical Analysis System (SAS ® ) Version 9.4 (SAS Institute, Inc, Cary, North Carolina).
We set two-tailed statistical significance at P < 0.05.
RESULTS
As shown in Table 1 , all 42 of the participants contributed data for our baseline analyses, and 39 contributed data for the analyses at 1 year.
At baseline, most semantic memory measures correlated highly (large effect size, r ≥ 0.50) or moderately (medium effect size, 0.50 > r ≥ 0.30) with each other; with global cognition (ADAS-cog), dementia severity (Clinical Dementia Rating sum of boxes), and daily function (Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory) ( Table 2) ; and with most other cognitive test scores (Appendix B). All correlations were in the expected direction. Semantic recognition and semantic naming from the Semantic Object Retrieval Test were highly correlated (r = 0.84).
At 1 year, correlations among semantic memory measures and between semantic memory measures and outcome measures were generally similar to those at baseline ( Table 2) . As expected, outcome measures also correlated highly with each other at baseline (r absolute values = 0.59 to 0.81) and 1 year (0.66 to 0.81).
For semantic memory tests, mean standardized 1-year change scores ranged from one-third to one-half standard deviation for the patients assessed at both time points (Table 3) . These change scores were higher than most, but not all, of the standardized change scores for the other neuropsychological tests (Appendix C).
In the factor analysis, a five-factor solution accounted for 97% of the variance (Table 4 ). The first of these uncorrelated factors (eigenvalue = 8.08, 67% of the variance explained) reflected search of the semantic lexicon as well as aspects of visual attention. We found high loadings for (in descending order) semantic density, narrative writing, and Part A of the Trail Making Test. Number cancellation, category fluency, and maze completion also loaded on this factor.
Factor 2 (eigenvalue = 1.34, 11% of variance) represented semantic retrieval and lexical retrieval, with the high loadings on semantic naming, semantic recognition, digit ordering, and confrontation naming.
Factor 3 (eigenvalue = 1.04, 8% of variance) incorporated aspects of executive functions, particularly those dependent on visuoconstruction and visual attention. The Mack et al, 1992. The fourth (eigenvalue = 0.85, 7% of variance) and fifth (eigenvalue = 0.67, 5% of variance) factors primarily represented aspects of episodic memory. Factor 4, which we designated learning, had high loadings on the East Boston Memory Test paragraph immediate recall, number cancellation, word list immediate recall, and the Mini-Mental State Examination. Factor 5, which we designated memory, had high loadings on word list delayed recall and the East Boston Memory Test paragraph delayed recall; category fluency also loaded on this factor.
In linear regression models to predict 1-year global cognition, dementia severity, and daily function, only the executive functions factor (factor 3) predicted all three outcomes (Table 5 ). The semantic-lexical retrieval factor (factor 2) independently predicted change in global cognition, and the memory factor (factor 5) independently predicted change in dementia severity.
In the models that considered baseline values of each of the semantic memory measures separately, significant predictors of 1-year outcomes were semantic recognition (for global cognition), category fluency (for dementia severity), and confrontation naming (also for dementia severity) ( Table 6 ). The baseline value of the semantic retrieval composite score also predicted change in global Bold type indicates correlations with nominally significant probabilities of P < 0.05. At baseline, correlations of ≥ 0.31 were nominally significant at P < 0.05; correlations of ≥ 0.40, at P < 0.01; correlations of ≥ 0.49, at P < 0.001; and correlations of ≥ 0.56, at P < 0.0001. At 1 year, correlations of ≥ 0.32 were nominally significant at P < 0.05; correlations of ≥ 0.41, at P < 0.01; correlations of ≥ 0.51, at P < 0.001; and correlations of ≥ 0.59, at P < 0.0001. *Calculated post hoc from semantic recognition and semantic naming, as described in the text.
†Higher values indicate greater impairment. 
DISCUSSION
During the raloxifene randomized clinical trial (Henderson et al, 2015) , values of most semantic memory tasks-oral confrontation naming, oral semantic fluency, oral semantic memory retrieval (recognition and naming), and written semantic density-correlated significantly with each other, but these five measures did not load on a common factor. Instead, they loaded on two uncorrelated factors and thus appear to distinguish two distinct aspects of semantic memory. The first aspect concerns processes in semantic retrieval and lexical retrieval: semantic recognition, semantic naming, and confrontation naming, ie, factor 2 of this study, semantic-lexical retrieval. The second aspect relates to processes in lexical search: semantic density in written discourse and category fluency, ie, factor 1 of this study, lexical search-visual attention. This dichotomy was not absolute, however, as confrontation naming contributed to a second factor, executive functions (factor 3), and category fluency contributed to a second factor, memory (factor 5). We adjusted the linear regression models for age, education, raloxifene versus placebo group, and baseline value of the outcome. Factors are in standard deviation units. A negative beta coefficient indicates that higher baseline values of a factor were associated with better global cognition, less severe dementia, and worse daily function at 1 year. *Nominal P < 0.05.
Global cognition, dementia severity, and daily function are related concepts used for dementia staging. Global cognition is a direct neuropsychological measure, daily function reflects the real-world consequences of neuropsychological and behavioral deficits, and dementia severity incorporates aspects of both. As we had hypothesized, in cross-sectional analyses semantic memory measures were significantly associated with dementia staging at baseline and-apart from nonsignificant correlations of confrontation naming and category fluency with daily function-with dementia staging at 1 year. Also, as hypothesized, some-although not mostbaseline semantic memory test scores were closely related to global cognition and dementia severity at 1 year. Contrary to our prediction, none of the baseline semantic memory test scores were related to daily function at 1 year.
Of the five unrelated cognitive factors, semantic-lexical retrieval predicted global cognition 1 year after baseline assessment, but lexical search-visual attention did not. Activities of daily living are closely related to neuropsychological measures of executive function (Martyr and Clare, 2012) . We found that the executive functions factor was the best overall predictor, in that it related not only to daily function, but also to global cognition and dementia severity outcomes. The memory factor (although not the learning factor) predicted dementia severity but, consistent with other reports (Locascio et al, 1995; Welsh et al, 1992) , neither the learning nor the memory factor predicted global cognitive decline in our sample of women with mild or moderate dementia.
Of the individual semantic memory measures, baseline values of both confrontation naming and category fluency predicted dementia severity at 1 year, and semantic recognition from the Semantic Object Retrieval Test predicted global cognition. Confrontation naming and category fluency, but not semantic recognition, are widely used in neuropsychological batteries to assess patients with Alzheimer disease in both clinical and research settings. At baseline, the semantic retrieval composite score-derived from semantic recognition and semantic naming scores-also predicted global cognition.
These results suggest that aspects of semantic memory may be sensitive predictors of disease severity and cognitive decline in patients with mild-to-moderate dementia from Alzheimer disease but do not predict functional decline. One-year change scores of one-third to one-half standard deviation for our individual semantic memory measures suggest that these tests should be sensitive to therapeutic interventions targeting cognitive impairment in patients at similar stages of their illness. We also found large mean 1-year change scores for immediate recall on the East Boston Memory Test and for maze completion. Semantic deficits can start earlier in the course of Alzheimer disease (Kraut et al, 2007; Verma and Howard, 2012 ), but we did not study participants with preclinical disease. Our results also support the usefulness of some executive function tasks in predicting and monitoring disease progression.
We derived each factor from correlated neuropsychological test scores, and the failure of our lexical searchvisual attention factor to predict 1-year outcomes could be explained by the inclusion of variables unrelated to lexical search. The sample size in this study was small, and our factor structure requires replication in larger cohorts of older adults at similar stages of dementia. Factor loadings might differ for cognitively normal women or for women with severe dementia. We did not include men in our sample, and patterns of cognitive impairment in dementia may differ between men and women (Buckwalter et al, 1996; Henderson and Buckwalter, 1994; Moreno-Martinez et al, 2008) .
Although half of our participants received raloxifene as part of the clinical trial, treatment should not have affected our findings. The intervention had no effect on the participants' cognition, disease severity, or daily function at 1 year, and we adjusted our analyses for whether participants were in the raloxifene or placebo group. We conducted separate linear regression analyses for each baseline predictor and outcome. We adjusted the models for age, education, raloxifene versus placebo group, and baseline value of the outcome. A negative beta coefficient indicates that better semantic memory at baseline was associated with better global cognition, less severe dementia, and worse daily function at 1 year. *Nominal P < 0.05. 2 Rosen et al, 1984. 3 Henderson et al, 2015. 4 MacDonald et al, 2001. 5 Reitan, 1958. 6 Mohs et al, 1997.
7 Goodglass et al, 2001 . Bold type indicates correlations with nominally significant probabilities of P < 0.05. Correlations of ≥ 0.31 were nominally significant at P < 0.05; correlations of ≥ 0.40, at P < 0.01; correlations of ≥ 0.49, at P < 0.001; and correlations of ≥ 0.56, at P < 0.0001. 1 Mack et al, 1992 Goodglass et al, 2001 . 12 Folstein et al, 1975 . EBMT = East Boston Memory Test.
